Literature DB >> 26944924

Trends and molecular mechanisms of antimicrobial resistance in clinical staphylococci isolated from companion animals over a 16 year period.

Natacha Couto1, Cláudia Monchique1, Adriana Belas1, Cátia Marques1, Luís T Gama2, Constança Pomba3.   

Abstract

OBJECTIVES: The objective of this study was to investigate the evolution of resistance to antimicrobials, corresponding mechanisms and molecular characteristics of Staphylococcus spp., between 1999 and 2014.
METHODS: Susceptibility to 38 antimicrobials was determined for 632 clinical staphylococcal isolates obtained from companion animals (dogs, cats, horses and other animals). Twenty antimicrobial resistance genes, including mecA and mecC, were screened by PCR. Methicillin-resistant staphylococci were characterized by spa (Staphylococcus aureus), SCCmec, MLST and PFGE typing. Statistical analyses were performed using SAS v9.3 and differences were considered relevant if P ≤ 0.05.
RESULTS: The mecA gene was identified in 74 staphylococcal isolates (11.6%): 11 MRSA (40.7%), 40 methicillin-resistant Staphylococcus pseudintermedius (MRSP; 8.7%) and 23 methicillin-resistant CoNS (26.7%). Resistance to the majority of antimicrobials and the number of mecA-positive isolates increased significantly over time. Eighteen spa types were identified, including two new ones. MRSA isolates were divided into three PFGE clusters that included ST22-IV, ST105-II, ST398-V and ST5-VI. Most methicillin-resistant Staphylococcus epidermidis isolates were of clonal complex (CC) 5, including a new ST, and clustered in eight PFGE clusters. MRSP were grouped into five PFGE clusters and included ST45-NT, ST71-II-III, ST195-III, ST196-V, ST339-NT, ST342-IV and the new ST400-III. Methicillin-resistant Staphylococcus haemolyticus clustered in two PFGE clusters.
CONCLUSIONS: The significant increase in antimicrobial-resistant and mecA-positive isolates in recent years is worrying. Furthermore, several isolates are MDR, which complicates antimicrobial treatment and increases the risk of transfer to humans or human isolates. Several clonal lineages of MRSA and methicillin-resistant S. epidermidis circulating in human hospitals and the community were found, suggesting that companion animals can become infected with and contribute to the dissemination of highly successful human clones. Urgent measures, such as determination of clinical breakpoints and guidelines for antimicrobial use, are needed.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26944924     DOI: 10.1093/jac/dkw029

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  25 in total

1.  Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study.

Authors:  Cátia Marques; Adriana Belas; Andreia Franco; Catarina Aboim; Luís Telo Gama; Constança Pomba
Journal:  J Antimicrob Chemother       Date:  2018-02-01       Impact factor: 5.790

2.  Prevalence, Mechanism, Genetic Diversity, and Cross-Resistance Patterns of Methicillin-Resistant Staphylococcus Isolated from Companion Animal Clinical Samples Submitted to a Veterinary Diagnostic Laboratory in the Midwestern United States.

Authors:  Mehmet Cemal Adiguzel; Kayla Schaefer; Trevor Rodriguez; Jessica Ortiz; Orhan Sahin
Journal:  Antibiotics (Basel)       Date:  2022-04-30

3.  Antimicrobial resistance in bacteria isolated from cats and dogs from the Atlantic Provinces, Canada from 1994-2013.

Authors:  Babafela B Awosile; J Trenton McClure; Matthew E Saab; Luke C Heider
Journal:  Can Vet J       Date:  2018-08       Impact factor: 1.008

Review 4.  Systematic Review on Global Epidemiology of Methicillin-Resistant Staphylococcus pseudintermedius: Inference of Population Structure from Multilocus Sequence Typing Data.

Authors:  Teresa Pires Dos Santos; Peter Damborg; Arshnee Moodley; Luca Guardabassi
Journal:  Front Microbiol       Date:  2016-10-18       Impact factor: 5.640

5.  Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Horses, Cats, and Dogs Over a 5-Year Period in France.

Authors:  Marisa Haenni; Pierre Châtre; Céline Dupieux-Chabert; Véronique Métayer; Michèle Bes; Jean-Yves Madec; Frédéric Laurent
Journal:  Front Microbiol       Date:  2017-12-13       Impact factor: 5.640

6.  Moving from information and collaboration to action: report from the 3rd International Dog Health Workshop, Paris in April 2017.

Authors:  Dan G O'Neill; Sylvia F A Keijser; Åke Hedhammar; Caroline Kisko; Gregoire Leroy; Aimée Llewellyn-Zaidi; Sofia Malm; Patricia N Olson; Rowena M A Packer; Jean Francois Rousselot; Ian J Seath; Jason W Stull; Brenda N Bonnett
Journal:  Canine Genet Epidemiol       Date:  2017-12-07

Review 7.  Bacteria from Animals as a Pool of Antimicrobial Resistance Genes.

Authors:  Maria Angeles Argudín; Ariane Deplano; Alaeddine Meghraoui; Magali Dodémont; Amelie Heinrichs; Olivier Denis; Claire Nonhoff; Sandrine Roisin
Journal:  Antibiotics (Basel)       Date:  2017-06-06

8.  Phenotypic and Molecular Traits of Staphylococcus coagulans Associated with Canine Skin Infections in Portugal.

Authors:  Sofia Santos Costa; Valéria Oliveira; Maria Serrano; Constança Pomba; Isabel Couto
Journal:  Antibiotics (Basel)       Date:  2021-05-02

9.  The SCCmec Types and Antimicrobial Resistance among Methicillin-Resistant Staphylococcus Species Isolated from Dogs with Superficial Pyoderma.

Authors:  Yuttana Chanayat; Areerath Akatvipat; Jeff B Bender; Veerasak Punyapornwithaya; Tongkorn Meeyam; Usanee Anukool; Duangporn Pichpol
Journal:  Vet Sci       Date:  2021-05-13

10.  Looking through Staphylococcus pseudintermedius infections: Could SpA be considered a possible vaccine target?

Authors:  Erika Grandolfo
Journal:  Virulence       Date:  2018-12-31       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.